Identification and functional characterization of the human EXT1 promoter region

Gene

Volumn 492, Issue 1, 2012, Pages 148-159

  Jennes, Ivy ^a   Zuntini, Monia ^b   Mees, Kirsten ^a   Palagani, Ajay ^a   Pedrini, Elena ^b   De Cock, Greet ^a   Fransen, Erik ^a   Vanden Berghe, Wim ^a   Sangiorgi, Luca ^b   Wuyts, Wim ^a,c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

ELISA; EMSA; EXT1; Luciferase assay; MO; Multiple osteochondromas

Indexed keywords

CCAAT BINDING FACTOR; EXOSTOSIN 1; HEPARAN SULFATE; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UPSTREAM STIMULATORY FACTOR 1;

ARTICLE; CARTILAGE; COMPUTER MODEL; CONTROLLED STUDY; CPG ISLAND; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC CODE; GENOTYPE PHENOTYPE CORRELATION; HEREDITARY MULTIPLE EXOSTOSIS; HUMAN; HUMAN TISSUE; METAPHYSIS; MULTIGENE FAMILY; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCHONDROMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FUNCTION; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

BASE SEQUENCE; CONSERVED SEQUENCE; EXOSTOSES, MULTIPLE HEREDITARY; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEQUENCE ALIGNMENT; TRANSCRIPTION INITIATION SITE; TRANSFECTION;

MAMMALIA;

EID: 84155180861     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.10.034     Document Type: Article

References (56)

1. Ahn J., et al. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1). Nat. Genet. 1995, 11:137-143.
2. Alvarez C.M., De Vera M.A., Heslip T.R., Casey B. Evaluation of the anatomic burden of patients with hereditary multiple exostoses. Clin. Orthop. Relat. Res. 2007, 462:73-79.
3. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 1991, 19:2499.
4. Beck J.A., Simpson D.J., Tisdall P.L. Surgical management of osteochondromatosis affecting the vertebrae and trachea in an Alaskan Malamute. Aust. Vet. J. 1999, 77:21-23.
5. Bellaiche Y., The I., Perrimon N. Tout-velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature 1998, 394:85-88.
6. Benoist-Lasselin C., et al. Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients. Bone 2006, 39:17-26.
7. Bornemann D.J., Duncan J.E., Staatz W., Selleck S., Warrior R. Abrogation of heparan sulfate synthesis in Drosophila disrupts the wingless, hedgehog and decapentaplegic signaling pathways. Development 2004, 131:1927-1938.
8. Bovée J.V., et al. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am. J. Hum. Genet. 1999, 65:689-698.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
10. Busse M., et al. Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation. J. Biol. Chem. 2007, 282:32802-32810.
11. De Andrea C.E., Wiweger M., Prins F., Bovee J.V., Romeo S., Hogendoorn P.C. Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma. Lab. Invest. 2010, 90:1091-1101.
12. Dobrovic A., Simpfendorfer D. Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res. 1997, 57:3347-3350.
13. Ernst H., Sander E., Karbe E., Nolte T., Mohr U. Osteochondroma in laboratory rats: a report of 3 cases in a Fischer-344, a Sprague-Dawley, and a Wistar rat. Toxicol. Pathol. 1992, 20:264-267.
14. Esteller M., et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl. Cancer Inst. 2000, 92:564-569.
15. Esteller M., et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 2000, 60:4366-4371.
16. Finotti A., Treves S., Zorzato F., Gambari R., Feriotto G. Upstream stimulatory factors are involved in the P1 promoter directed transcription of the A beta H-J-J locus. BMC Mol. Biol. 2008, 9:110.
17. Francannet C., Cohen-Tanugi A., Le Merrer M., Munnich A., Bonaventure J., Legeai-Mallet L. Genotype-phenotype correlation in hereditary multiple exostoses. J. Med. Genet. 2001, 38:430-434.
18. Gonzalez-Zulueta M., et al. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res. 1995, 55:4531-4535.
19. Hameetman L., et al. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas. J. Pathol. 2007, 211:399-409.
20. Han C., Belenkaya T.Y., Khodoun M., Tauchi M., Lin X. Distinct and collaborative roles of Drosophila EXT family proteins in morphogen signalling and gradient formation. Development 2004, 131:1563-1575.
21. Hennekam R.C. Hereditary multiple exostoses. J. Med. Genet. 1991, 28:262-266.
22. Herman J.G., et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:9700-9704.
23. Iwata H., et al. A case of multiple osteochondroma in the rat. J. Vet. Med. Sci. 1995, 57:339-340.
24. Jennes I., Entius M.M., Van Hul E., Parra A., Sangiorgi L., Wuyts W. Mutation screening of EXT1 and EXT2 by denaturing high-performance liquid chromatography, direct sequencing analysis, fluorescence in situ hybridization, and a new multiplex ligation-dependent probe amplification probe set in patients with multiple osteochondromas. J. Mol. Diagn. 2008, 10:85-92.
25. Jennes I., et al. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb). Hum. Mutat. 2009, 30:1620-1627.
26. Jones K.B., et al. A mouse model of osteochondromagenesis from clonal inactivation of Ext1 in chondrocytes. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:2054-2059.
27. Kramer M.A., Rettie A.E., Rieder M.J., Cabacungan E.T., Hines R.N. Novel CYP2C9 promoter variants and assessment of their impact on gene expression. Mol. Pharmacol. 2008, 73:1751-1760.
28. Larsen F., Gundersen G., Lopez R., Prydz H. CpG islands as gene markers in the human genome. Genomics 1992, 13:1095-1107.
29. Ludecke H.J., et al. Genomic organization and promoter structure of the human EXT1 gene. Genomics 1997, 40:351-354.
30. Ludecke H.J., et al. Genes and chromosomal breakpoints in the Langer-Giedion syndrome region on human chromosome 8. Hum. Genet. 1999, 105:619-628.
31. Marino F., Salvaggio A., Macri D. Congenital retroparietal fibrolipoma and osteochondroma in a calf. Vet. Rec. 2006, 158:772.
32. Matsumoto K., Irie F., Mackem S., Yamaguchi Y. A mouse model of chondrocyte-specific somatic mutation reveals a role for Ext1 loss of heterozygosity in multiple hereditary exostoses. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:10932-10937.
33. Mozos E., Novales M., Ginel P.J., Perez J., Pool R.R. A newly recognized pattern of canine osteochondromatosis. Vet. Radiol. Ultrasound 2002, 43:132-137.
34. Myers R.M., et al. A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 2011, 9:e1001046.
35. Ohtani-Fujita N., Fujita T., Aoike A., Osifchin N.E., Robbins P.D., Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene 1993, 8:1063-1067.
36. Porter D.E., et al. Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study. J. Bone Joint Surg. Br. 2004, 86:1041-1046.
37. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
38. Reijnders C.M., et al. No haploinsufficiency but loss of heterozygosity for EXT in multiple osteochondromas. Am. J. Pathol. 2010, 177:1946-1957.
39. Ropero S., et al. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells. Hum. Mol. Genet. 2004, 13:2753-2765.
40. Schmale G.A., Conrad E.U., Raskind W.H. The natural history of hereditary multiple exostoses. J. Bone Joint Surg. Am. 1994, 76:986-992.
41. Siekmann A.F., Brand M. Distinct tissue-specificity of three zebrafish ext1 genes encoding proteoglycan modifying enzymes and their relationship to somitic Sonic hedgehog signaling. Dev. Dyn. 2005, 232:498-505.
42. Signori E., et al. A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients. Genes Chromosomes Cancer 2007, 46:470-477.
43. Silver G.M., Bagley R.S., Gavin P.R., Kippenes H. Radiographic diagnosis: cartilaginous exostoses in a dog. Vet. Radiol. Ultrasound 2001, 42:231-234.
44. Stickens D., et al. The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes. Nat. Genet. 1996, 14:25-32.
45. Szuhai K., et al. Tiling resolution array-CGH shows that somatic mosaic deletion of the EXT gene is causative in EXT gene mutation negative multiple osteochondromas patients. Hum. Mutat. 2011, 32:E2036-E2049.
46. Takei Y., Ozawa Y., Sato M., Watanabe A., Tabata T. Three Drosophila EXT genes shape morphogen gradients through synthesis of heparan sulfate proteoglycans. Development 2004, 131:73-82.
47. Tamura G., et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J. Natl. Cancer Inst. 2000, 92:569-573.
48. Tsuchiya T., et al. Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 2000, 19:3642-3646.
49. Tsuchiya T., et al. Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma. Cancer Genet. Cytogenet. 2005, 158:148-155.
50. Van Hul W., et al. Identification of a third EXT-like gene (EXTL3) belonging to the EXT gene family. Genomics 1998, 47:230-237.
51. Wicklund C.L., Pauli R.M., Johnston D., Hecht J.T. Natural history study of hereditary multiple exostoses. Am. J. Med. Genet. 1995, 55:43-46.
52. Wise C.A., Clines G.A., Massa H., Trask B.J., Lovett M. Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. Genome Res. 1997, 7:10-16.
53. Wuyts W., et al. Positional cloning of a gene involved in hereditary multiple exostoses. Hum. Mol. Genet. 1996, 5:1547-1557.
54. Wuyts W., et al. Identification and characterization of a novel member of the EXT gene family, EXTL2. Eur. J. Hum. Genet. 1997, 5:382-389.
55. Wuyts W., Radersma R., Storm K., Vits L. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas. Clin. Genet. 2005, 68:542-547.
56. Yoshiura K., Kanai Y., Ochiai A., Shimoyama Y., Sugimura T., Hirohashi S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:7416-7419.